Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
---|---|---|---|---|---|
Log P | 3.3 | - | 3.3 | - | https://comptox.epa.gov/dashboard/dsstoxdb/results?formula=1&isotopes=1&search=C24H31ClN2O10 |
Boiling Point | 413.0 | ℃ | 413 | ℃ | https://comptox.epa.gov/dashboard/dsstoxdb/results?formula=1&isotopes=1&search=C24H31ClN2O10 |
Melting Point | 138.0 | ℃ | 138 | ℃ | https://comptox.epa.gov/dashboard/dsstoxdb/results?formula=1&isotopes=1&search=C24H31ClN2O10 |
Water Solubility | 81000.0 | mg/L | 81 | mg/ml | http://www.selleckchem.com/products/levamlodipine.html |
pKa | 8.6 | - | 8.6 | - | FDA Label |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
AUC | 351.0 | ng.h/ml | 351±72 | ng.h/ml | PO, oral; Derivative; | DRUGBANK | AUC | 330.0 | ng.h/ml | 330±88 | ng.h/ml | PO, oral; Derivative; | DRUGBANK |
Bioavailability | 77.0 | % | 64-90 | % | PO, oral; | DRUGBANK |
C Max | 6.1 | ng/ml | 6.13±1.29 | ng/ml | PO, oral; Derivative; | DRUGBANK | C Max | 5.1 | ng/ml | 5.07±1.09 | ng/ml | PO, oral; Derivative; | DRUGBANK |
T Max | 9.0 | h | 6-12 | h | PO, oral; | DRUGBANK | T Max | 8.4 | h | 8.4±3.6 | h | PO, oral; Derivative; | DRUGBANK | T Max | 10.7 | h | 10.7±3.4 | h | PO, oral; Derivative; | DRUGBANK |
Metabolic | 90.0 | % | 90 | % | Liver metabolism; Inactive metabolite; | DRUGBANK |
Clearance | 0.41 | L/h/kg | 6.9±1.6 | ml/min/kg | PO, oral; | DRUGBANK | Clearance | 0.44 | L/h/kg | 7.3±2.1 | ml/min/kg | PO, oral; | DRUGBANK |
Volume of Distribution | 21.0 | L/kg | 21.0 | L/kg | DRUGBANK | |
Half-life | 40.0 | h | 30-50 | h | DRUGBANK | |
Eliminate Route | 60.0 | % | 60 | % | Urinary excretion; | DRUGBANK |
Protein Binding | 93.0 | % | 93 | % | plasma proteins; | DRUGBANK |
Not Available